Inhibrx, Inc. (INBX) Misses Q3 EPS by 71c

Inhibrx, Inc. (NASDAQ: INBX) reported Q3 EPS of ($2.28), $0.71 worse than the analyst estimate of ($1.57).

For earnings history and earnings-related data on Inhibrx, Inc. (INBX) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Cytek faces $56M damages award in Beckman Coulter patent case